BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 16135590)

  • 1. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.
    Ness RB; Trautmann G; Richter HE; Randall H; Peipert JF; Nelson DB; Schubeck D; McNeeley SG; Trout W; Bass DC; Soper DE
    Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
    Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
    Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to oral therapies in pelvic inflammatory disease.
    Dunbar-Jacob J; Sereika SM; Foley SM; Bass DC; Ness RB
    J Womens Health (Larchmt); 2004 Apr; 13(3):285-91. PubMed ID: 15130257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline.
    Wølner-Hanssen P; Paavonen J; Kiviat N; Young M; Eschenbach DA; Holmes KK
    Obstet Gynecol; 1988 Apr; 71(4):595-600. PubMed ID: 3353051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
    Heinonen PK; Leinonen M
    Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease.
    Walters MD; Gibbs RS
    Obstet Gynecol; 1990 May; 75(5):867-72. PubMed ID: 2183112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ciprofloxacin/metronidazole vs. cefoxitin/doxycycline: comparison of two therapy schedules for treatment of acute pelvic infection].
    Fischbach F; Deckardt R; Graeff H
    Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):337-40. PubMed ID: 8088489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
    Piyadigamage A; Wilson J
    Sex Transm Infect; 2005 Jun; 81(3):233-5. PubMed ID: 15923292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease.
    Soper DE; Despres B
    Obstet Gynecol; 1988 Jul; 72(1):7-12. PubMed ID: 3132668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations and rationale for the treatment of pelvic inflammatory disease.
    Jaiyeoba O; Lazenby G; Soper DE
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):61-70. PubMed ID: 21171878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial vaginosis and risk of pelvic inflammatory disease.
    Ness RB; Hillier SL; Kip KE; Soper DE; Stamm CA; McGregor JA; Bass DC; Sweet RL; Rice P; Richter HE
    Obstet Gynecol; 2004 Oct; 104(4):761-9. PubMed ID: 15458899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial.
    Savaris RF; Teixeira LM; Torres TG; Edelweiss MI; Moncada J; Schachter J
    Obstet Gynecol; 2007 Jul; 110(1):53-60. PubMed ID: 17601896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pelvic inflammatory disease.
    Cunha BA
    Clin Pharm; 1990 Apr; 9(4):275-85. PubMed ID: 2184973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease.
    Trent M; Chung SE; Forrest L; Ellen JM
    Arch Pediatr Adolesc Med; 2008 Nov; 162(11):1022-5. PubMed ID: 18981349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of pelvic inflammatory disease.
    Crossman SH
    Am Fam Physician; 2006 Mar; 73(5):859-64. PubMed ID: 16529095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic inflammatory disease: a contemporary approach.
    Newkirk GR
    Am Fam Physician; 1996 Mar; 53(4):1127-35. PubMed ID: 8629562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
    Haggerty CL; Ness RB
    Clin Infect Dis; 2007 Apr; 44(7):953-60. PubMed ID: 17342647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPs should be vigilant for pelvic inflammatory disease.
    Soleymani majd H; Ismail L; Currie I
    Practitioner; 2011 Mar; 255(1738):15-8, 2. PubMed ID: 21510504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women.
    Ness RB; Hillier SL; Kip KE; Richter HE; Soper DE; Stamm CA; McGregor JA; Bass DC; Rice P; Sweet RL
    Am J Epidemiol; 2005 Jan; 161(2):186-95. PubMed ID: 15632269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.